What we have learnt from SARS epidemics in China

British Medical Journal

Volumn 333, Issue 7564, 2006, Pages 389-391

  Zhong, Nanshan ^a,b   Zeng, Guangqiao ^a  

^a GUANGZHOU MEDICAL UNIVERSITY   (China)

^b Chinese Medical Association   (China)

Author keywords

[No Author keywords available]

Indexed keywords

CHINA; CHLAMYDIA; CLINICAL FEATURE; EPIDEMIC; HEALTH CENTER; HONESTY; HUMAN; LUNG PARENCHYMA; NOTE; PATHOGENESIS; PHYSICIAN; PRIORITY JOURNAL; SARS CORONAVIRUS; SEVERE ACUTE RESPIRATORY SYNDROME; DISEASE TRANSMISSION; REVIEW;

CHINA; DISEASE OUTBREAKS; HUMANS; SEVERE ACUTE RESPIRATORY SYNDROME;

EID: 33747596934     PISSN: 09598146     EISSN: None     Source Type: Journal    
DOI: 10.1136/bmj.333.7564.389     Document Type: Note

References (15)

1. Zhong NS, Zeng GQ. Management and prevention of SARS in China. In: McLean AR, May RM, Pattison J, Weiss RA, eds. SARS; a case study in emerging infections. London: Oxford University Press, 2005:31-4.
2. Zheng L. Management strategies for SARS and other emerging public health events. Beijing: Science Press, 2003:106. (In Chinese.)
3. Ksiazek TG, Erdman D, Goldsmith C, Zaki SR, Peret T, Emery S, et al. A novel coronavirus associated with severe acute respiratory syndrome. N Engl J Med 2003;348:1953-66.
4. Zhong NS, Zheng BJ, Li YM, Poon, Xie ZH, Chan KH. Epidemiology and cause of severe acute respiratory syndrome (SARS) in Guangdong, People's Republic of China, in February, 2003. Lancet 2003;362:1353-8.
5. Enserink M. SARS in China: China's Missed Chance. Science 2003;301:294-6.
6. Yu D, Li H, Xu R, He J, Lin J, Li L, et al. Prevalence of IgG antibody to SARS-associated coronavirus in animal traders-Guangdong province, China, 2003. Mort Mort Wkl Rep 2003;52:986-7.
7. Xu RH, He JF, Evans MR, Peng GW, Field HE, Yu DW, et al. Epidemiologic clues to SARS origin in China. Emerg Infect Dis 2004;10:1030-7.
8. Guan Y, Zheng BJ, He YQ, Liu XL, Zhuang ZX, Cheung CL, et al. Isolation and characterization of viruses related to the SARS coronavirus from animals in southern China. Science 2003;302:276-8.
9. BBC News. Threat of new SARS outbreak 'low', http://news.bbc.co.uk/1/ low/health/4280253.stm (accessed 29 Jun 2006)
10. Henderson M. End of Sars as a deadly threat. 21 Feb 2005. www.timesonline.co.uk/printFriendly/0,1-3-1493050,00.html (accessed 29 Jun 2006).
11. Song DH, Tu CC, Zhang GW, Wang SY, Zheng K, Lei LC, et al. Cross-host evolution of severe acute respiratory syndrome coronavirus in palm civet and human. PNAS 2005;102:2430-5.
12. Tu C, Crameri G, Kong X, Chen J, Sun Y, Yu M, et al. Antibodies to SARS coronavirus in civets. Emerg Infect Dis 2004;10:2244-8.
13. Wu D, Tu C, Xin C, Xuan H, Meng Q, Liu Y, et al. Civets are equally susceptible to experimental infection by two different severe acute respiratory syndrome coronavirus isolates. J Virol 2005;79:2620-5.
14. Li WD, Shi ZL, Yu M, Ren WZ, Smith C, Epstein JH, et al. Bats are natural reservoirs of SARS-like coronaviruses. Science 2005;310:676-9.
15. Li BJ, Tang Q, Cheng D, Qin C, Xie FY, Wei Q, et al. Using siRNA in prophylactic and therapeutic regimens against SARS coronavirus in Rhesus macaque. Nat Med 2005;11:944-51.